ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 41 filers reported holding ADC THERAPEUTICS SA in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,488 | -58.3% | 19,496 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $41,916 | +10.3% | 19,496 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $38,017 | -49.2% | 19,496 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $74,865 | -20.4% | 19,496 | -0.0% | 0.00% | -50.0% |
| Q3 2022 | $94,000 | -39.4% | 19,502 | +0.0% | 0.00% | -20.0% |
| Q2 2022 | $155,000 | -45.8% | 19,497 | +0.1% | 0.01% | -54.5% |
| Q1 2022 | $286,000 | -27.4% | 19,469 | -0.2% | 0.01% | -31.2% |
| Q4 2021 | $394,000 | -25.7% | 19,505 | -0.0% | 0.02% | -33.3% |
| Q3 2021 | $530,000 | +11.6% | 19,514 | +0.0% | 0.02% | +9.1% |
| Q2 2021 | $475,000 | -0.2% | 19,507 | +0.0% | 0.02% | -12.0% |
| Q1 2021 | $476,000 | – | 19,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,186,215 | $4,555,066 | 2.69% |
| Blue Owl Capital Holdings LP | 733,568 | $2,816,901 | 1.20% |
| Redmile Group, LLC | 7,590,849 | $29,148,860 | 1.19% |
| AlphaCentric Advisors LLC | 297,500 | $1,142,400 | 1.13% |
| Prosight Management, LP | 463,310 | $1,779,110 | 0.97% |
| GCM Grosvenor Holdings, LLC | 735,471 | $2,824,209 | 0.72% |
| Indie Asset Partners, LLC | 93,839 | $360,342 | 0.40% |
| XTX Topco Ltd | 197,635 | $758,918 | 0.16% |
| Eventide Asset Management | 1,879,959 | $7,219,043 | 0.14% |
| Nantahala Capital Management | 243,290 | $934,234 | 0.06% |